Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.
about
Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived BiomarkersQuantitative and Qualitative Analysis of Circulating Cell-Free DNA Can Be Used as an Adjuvant Tool for Prostate Cancer Screening: A Meta-AnalysismiR-24-3p Suppresses Malignant Behavior of Lacrimal Adenoid Cystic Carcinoma by Targeting PRKCH to Regulate p53/p21 Pathway.Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes?MicroRNA Profile of Lung Tumor Tissues Is Associated with a High Risk Plasma miRNA Signature.Progress and prospects of early detection in lung cancer.Systematic review and critique of circulating miRNAs as biomarkers of stage I-II non-small cell lung cancer.MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening.Is MicroRNA-127 a Novel Biomarker for Acute Pancreatitis with Lung Injury?Circulating and tumor-associated caspase-4: a novel diagnostic and prognostic biomarker for non-small cell lung cancer.Lung Cancer Field Cancerization: Implications for Screening by Low-Dose Computed Tomography.microRNA-451a regulates colorectal cancer proliferation in response to radiation.miR-93-5p enhance lacrimal gland adenoid cystic carcinoma cell tumorigenesis by targeting BRMS1L.Metabolome-based biomarkers: their potential role in the early detection of lung cancer
P2860
Q26741204-E8E9F80D-28AF-4B2F-9368-036715D445C1Q28072148-11244227-844F-4568-92C2-BDF768A7A608Q36063003-38EFE297-7706-4479-B130-E9190279DF31Q39142265-EAA26876-9228-4020-BAF8-D5665DE39F36Q41213400-EF61BC8E-78F1-449C-9F19-0FCF807CB852Q42139806-F4097B42-BF83-44E6-9592-84F12C469089Q47106442-9437C5D1-B3D3-4935-80AC-A67EFCE20D5BQ49212856-486EB181-3316-43B9-A0A5-3FD3DB2BB27BQ49738962-D88CD6B7-D228-474F-8CEA-50DB1A9AA7F4Q52714341-D86CB257-A7BA-4687-AF8D-2178D6712685Q54763099-58ACCA2C-CB27-488F-8E08-C13EEFAA6367Q55154231-F03F0705-6E99-4506-9988-1FC81A49495BQ55251938-D8EB605B-2915-4105-BF48-E691C42A2D45Q59129088-56583B83-4C28-41DA-932A-3252AD4933D9
P2860
Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Circulating microRNA signature ...... computed tomography screening.
@ast
Circulating microRNA signature ...... computed tomography screening.
@en
type
label
Circulating microRNA signature ...... computed tomography screening.
@ast
Circulating microRNA signature ...... computed tomography screening.
@en
prefLabel
Circulating microRNA signature ...... computed tomography screening.
@ast
Circulating microRNA signature ...... computed tomography screening.
@en
P2093
P2860
P50
P356
P1433
P1476
Circulating microRNA signature ...... computed tomography screening.
@en
P2093
Alfonso Marchiano
Carlotta Galeone
Giuseppe Pelosi
Paola Suatoni
P2860
P304
32868-32877
P356
10.18632/ONCOTARGET.5210
P407
P50
P577
2015-10-06T00:00:00Z